Clinical Trial Update: The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism [NA]

View source ↗

Summary

A completed trial evaluating the effect of E-EPA on circulating LDL and plasma lipid metabolism, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases

Drugs mentioned

• E-EPA (ethyl-eicosapentaenoic acid)

Snippet

Sponsor: Wihuri Research Institute | Conditions: Atherosclerosis, Low-density Lipoproteins Aggregation Susceptibility | NA | Status: COMPLETED | Results posted: 2025-09-22